CARMIEL, Israel--(BUSINESS WIRE)--Protalix BioTherapeutics, Inc. (NYSE-AMEX: PLX), today announced that Dr. David Aviezer, the Company’s President and Chief Executive Officer, will be presenting at 8th Annual Needham Life Sciences Conference in New York and the 8th National Life Science and Technology Week ISLI-Biomed Israel 2009. Additionally, Dr. Einat Brill Almon, the Company’s Senior Vice President of Product Development, will be presenting at the 3rd International Conference on Plant-Based Vaccines & Antibodies in Italy.
